Series 5: episode 10
To bring season 5 of the GOLD podcast to a close, join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.
In this episode, Jade and Christy unpick her transition from general medicine to women’s cancer, how companies can best extend oncology care to those with disabilities, ways to expand diversity, equity and inclusion schemes to better support those living with disabilities and more.
A little more on GOLD’s guest…
Christy Siegel is General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, where she acts as a purpose-driven leader with extensive knowledge of the US commercial market. Her specialty areas include respiratory and transplantation. She also prides herself on championing diversity, creative cultures and collaboration within the industry.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Podcast: Translating policy into action
Last week’s episode: Season 5 highlights: GOLD Medal Moments